Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
NCT Number: NCT00126854
The purpose of this study is to establish the correct scanning parameters for obtaining good quality 3 Tesla (3T) magnetic resonance spectroscopy images (MRSI) of the prostate gland before and after brachytherapy implantation for prostate cancer. Three Tesla MRSI may be a valuable additional diagnostic and follow-up investigation for prostate cancer patients.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Edmonton, Alberta, T6G 1Z2, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
AHS Cancer Control Alberta
Other
High Field (3 Tesla) Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Permanent Iodine 125 Brachytherapy Implantation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03935282
Behavior, Breast Diseases
Fort Smith, Arkansas, United States
View Trial DetailsNCT01314118
Genital Diseases, Genital Diseases, Male
Homewood, Alabama, United States
View Trial DetailsNCT05162573
Genital Diseases, Genital Diseases, Male
Amsterdam, Netherlands
View Trial DetailsNCT03939689
Cancer of the Prostate, Castration-resistant Prostate Cancer
Duarte, California, United States
View Trial Details